Holen Sie sich die Stockscreener-App
47.45
0.19%
-0.105
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Ucleic Acid Amplification Testing Market Set for Dynamic - openPR.com
What’s next for Qiagen N.V. stockJuly 2025 Closing Moves & Technical Confirmation Trade Alerts - beatles.ru
Can swing trading help recover from Qiagen N.V. lossesWeekly Trend Recap & Accurate Technical Buy Alerts - Newser
Is Qiagen N.V. forming a bullish divergenceJuly 2025 Selloffs & Smart Allocation Stock Tips - 강소기업뉴스
What are analysts’ price targets for Qiagen N.V.July 2025 Breakouts & Accurate Buy Signal Alerts - خودرو بانک
Qiagen N.V. Announces Voting Rights Notification by AFM - MSN
Analyzing recovery setups for Qiagen N.V. investorsBond Market & Verified High Yield Trade Plans - Newser
Qiagen N.V. stock prediction for this weekJuly 2025 Short Interest & AI Enhanced Execution Alerts - Newser
Oncology Molecular Diagnostics Market Size Drives USD 9.76 Billion by 2034 - GlobeNewswire Inc.
Is Qiagen N.V. still worth holding after the dipPortfolio Value Report & Safe Entry Momentum Tips - Newser
RNA Editing Market Top PlayersQIAGEN N.V., UniquQuire NV, LAVA - openPR.com
Real time social sentiment graph for Qiagen N.V.July 2025 Pullbacks & High Yield Stock Recommendations - Newser
QIAGEN NV : Jefferies reaffirms its Buy rating - MarketScreener
What analysts say about Qiagen N.V. stock2025 Macro Impact & Free Real-Time Market Sentiment Alerts - خودرو بانک
QGEN Stock Likely to Gain From Innovation Amid Competition - MSN
Investors in Qiagen (NYSE:QGEN) have unfortunately lost 4.9% over the last five years - Yahoo Finance
Chart based analysis of Qiagen N.V. trendsWeekly Risk Summary & Daily Technical Forecast Reports - Newser
Qiagen N.V. stock trend forecastChart Signals & Entry Point Confirmation Alerts - Newser
Will Qiagen N.V. outperform the market2025 Market Trends & Long Hold Capital Preservation Plans - Newser
Does Qiagen N.V. meet Warren Buffett’s criteria2025 Geopolitical Influence & Verified Short-Term Plans - خودرو بانک
Long term hold vs stop loss in Qiagen N.V.Weekly Profit Summary & Long Hold Capital Preservation Tips - Newser
Will Qiagen N.V. stock go up soonWeekly Trend Recap & Stock Portfolio Risk Control - Newser
Volatility Watch: What are analysts’ price targets for Qiagen N.V.July 2025 Weekly Recap & Verified Trade Idea Suggestions - خودرو بانک
Is Qiagen N.V. stock a good dividend stockPortfolio Profit Report & Long-Term Safe Investment Ideas - خودرو بانک
Is Qiagen N.V. stock showing strong momentumJuly 2025 Review & Low Risk High Reward Trade Ideas - خودرو بانک
Multi asset correlation models including Qiagen N.V.Earnings Beat & Technical Buy Zone Confirmation - Newser
QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx Rise - TradingView
FDA clears Qiagen’s next-gen syndrome panel - Medical Device Network
When is the best time to exit Qiagen N.V.2025 Market WrapUp & Expert Approved Trade Ideas - Newser
Earnings visualization tools for Qiagen N.V.Portfolio Gains Report & Long Hold Capital Preservation Plans - Newser
Can Qiagen N.V. expand into new marketsJuly 2025 Fed Impact & Verified Stock Trade Ideas - خودرو بانک
Is now a turning point for Qiagen N.V.Fed Meeting & Accurate Entry/Exit Alerts - Newser
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing - sharewise.com
Qiagen N.V.’s volatility index tracking explainedWeekly Trend Recap & Smart Money Movement Tracker - Newser
Qiagen’s Voting Rights Announcement Involves BlackRock’s Significant Holdings - MSN
Qiagen's (NYSE:QGEN) Strong Earnings Are Of Good Quality - simplywall.st
Hemato-Oncology Testing Market Size, Share & Trends Analysis Report 2025-2030 Featuring Key Players Roche, Abbott, EntroGen, Qiagen, and Cepheid (Danaher) Among Others - Yahoo Finance
Qiagen shares rise 1.53% premarket after FDA clearance of higher-throughput QIAstat-Dx Rise system. - AInvest
QIAGEN N.V. Launches QIAstat-Dx Rise, a High-Throughput Automated Syndromic Testing System with FDA Clearance. - AInvest
How does Qiagen N.V. score in quality rankings2025 Top Decliners & Long-Term Safe Return Strategies - خودرو بانک
How to escape a deep drawdown in Qiagen N.V.July 2025 Earnings & Risk Adjusted Buy and Sell Alerts - Newser
Is Qiagen N.V. currently under institutional pressure2025 Price Momentum & Growth Oriented Trading Recommendations - beatles.ru
QIAGEN receives FDA clearance for higher-throughput diagnostic system - StreetInsider
Qiagen Says US FDA Clears Syndromic Testing System - 富途牛牛
US FDA Clears Qiagen's Syndromic Testing System - AInvest
Qiagen Gains US Clearance for Higher-Throughput QIAstat-Dx Rise - AInvest
QIAGEN Introduces QIAstat-Dx Rise: A Higher-Throughput Automated Syndromic Testing System Cleared by FDA. - AInvest
Qiagen gains U.S. clearance of higher-throughput QIAstat-Dx Rise - MarketScreener
Does Qiagen N.V. have a sustainable dividend2025 Trading Volume Trends & AI Driven Price Predictions - خودرو بانک
Real time pattern detection on Qiagen N.V. stockJuly 2025 Sentiment & Verified Momentum Watchlists - Newser
Qiagen grabbed 'opportunistic window' to sell $750m CB - GlobalCapital
Can Qiagen N.V. be the next market leaderJuly 2025 Update & Daily Growth Stock Tips - خودرو بانک
0.43%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):